
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+11
Smartlens is a late-stage clinical company developing breakthrough technologies that are transforming the management of glaucoma, a leading cause of irreversible blindness, and other anterior segment eye diseases. Its flagship product, miLens, is a novel, non-invasive contact lens-based device designed to monitor intraocular pressure (IOP), the primary risk factor for glaucoma. miLens utilizes an electronics-free, ultra-sensitive IOP monitoring system to address a significant unmet need in glaucoma management that has persisted since the 1950s. Strong clinical results for miLens were presented at the 2023 and 2024 American Glaucoma Society meetings, with commercialization planned for 2025. miLens is protected by issued...
Ophthalmology,glaucoma,iop,medical devices,smart contact lens,personalized treatment,precision medicine,ai in healthcare,digital health,glioblastoma,icp,neuroscience,remote patient monitoring,optometry,home iop monitoring,and eye pressure monitoring
Smartlens operates in the Medical equipment manufacturing industry.
Smartlens's revenue is 11m - 100m
Smartlens has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.